Adrien Jolly is a postdoctoral researcher who completed his PhD at the German Cancer Research Center (DKFZ) in Heidelberg under the supervision of Prof. Thomas Höfer.
He is working on quantification of pathological and normal human blood cell development using omics data. His project is co-hosted by the labs of Prof. Büttner and Prof. Michael Rieger from the Universitätsklinikum Frankfurt and is funded by the Mildred-Scheel-Nachwuchszentrum Frankfurt.